NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
-3.96%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
10 Year Return
AUM
$312M
AUM Growth
+$312M
Cap. Flow
+$84.5M
Cap. Flow %
27.06%
Top 10 Hldgs %
89.79%
Holding
29
New
5
Increased
5
Reduced
1
Closed
1

Sector Composition

1 Healthcare 67.1%
2 Financials 30.02%
3 Communication Services 0.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NFH
1
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$93.8M 30.02% 8,350,000
ILMN icon
2
Illumina
ILMN
$15.8B
$52.6M 16.83% +129,647 New +$52.6M
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$29.5M 9.43% 768,708
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$28.7M 9.19% 234,811
SLGC
5
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$21M 6.73% +1,696,558 New +$21M
EAR
6
DELISTED
Eargo, Inc. Common Stock
EAR
$19.4M 6.22% 2,886,724
BOLT icon
7
Bolt Biotherapeutics
BOLT
$9.85M
$14.8M 4.73% 1,166,952
RANI icon
8
Rani Therapeutics
RANI
$24.4M
$8.8M 2.82% +493,584 New +$8.8M
VIR icon
9
Vir Biotechnology
VIR
$686M
$6.97M 2.23% 160,211 +91,548 +133% +$3.98M
GRTX
10
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$4.97M 1.59% 613,223
BEAM icon
11
Beam Therapeutics
BEAM
$1.66B
$4.78M 1.53% 54,903 +6,243 +13% +$543K
NFH.WS
12
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$4.46M 1.43% 1,580,000
NVTA
13
DELISTED
Invitae Corporation
NVTA
$4.11M 1.32% 144,667
ALXO icon
14
ALX Oncology
ALXO
$62.7M
$3.1M 0.99% 41,950 +7,000 +20% +$517K
XENE icon
15
Xenon Pharmaceuticals
XENE
$2.98B
$3.02M 0.97% 197,880
DBVT
16
DBV Technologies
DBVT
$264M
$1.82M 0.58% 370,950 +85,450 +30% +$419K
EXAS icon
17
Exact Sciences
EXAS
$8.98B
$1.67M 0.53% 17,464
OTIC
18
DELISTED
Otonomy, Inc.
OTIC
$1.63M 0.52% 851,000
KALV icon
19
KalVista Pharmaceuticals
KALV
$678M
$1.37M 0.44% 78,720
EXEL icon
20
Exelixis
EXEL
$10.1B
$1.36M 0.43% 64,200
SRRA
21
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.16M 0.37% 52,979 -78,000 -60% -$1.71M
RUBY
22
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.02M 0.32% 56,768
RETA
23
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$832K 0.27% 8,265
STSA
24
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$666K 0.21% +142,900 New +$666K
FLNT
25
Fluent
FLNT
$57.8M
$442K 0.14% 194,800 +1 +0% +$2